More on ROP
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $350.69 |
|
|||
| Open | $350.69 | ||||
| 52 Wk High | $195.93 | ||||
| 52 Wk Low | $155.79 | ||||
| Day High | $352.07 | ||||
| Day Low | $335.50 | ||||
| P/E | 62.70 | ||||
| EPS | $5.37 | ||||
| Volume | 975,554 | ||||
- Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges
- Raymond James Downgrades Roper Industries (ROP) to Market Perform
- Roper Industries (ROP) PT Lowered to $335 at Mizuho
- Roche names new diagnostics North America chief, effective Aug. 1
- Roche Appoints Dan Malarek as President and CEO of Roche Diagnostics North America
- FDA grants priority review to Genentech's Gazyva for kidney disease
- FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy
- Aderant CEO Chris Cartrett to depart for ImageTrend role
- Aderant’s Chris Cartrett to Conclude Tenure as President & CEO
- BMO Capital Starts Roper Industries (ROP) at Market Perform
Entities mentioned with rop
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- Third Point LLC | View Related Stories »
- Show More...
